AAAAAA

   
Results: 1-13 |
Results: 13
FREQUENCY OF TRISOMY-20 IN NONMALIGNANT BRONCHIAL EPITHELIUM FROM LUNG-CANCER PATIENTS AND CANCER-FREE FORMER URANIUM MINERS AND SMOKERS
Authors: NEFT RE CROWELL RE GILLILAND FD MURPHY MM LANE JL HARMS H COONS T HEAPHY E BELINSKY SA LECHNER JF
Citation: Re. Neft et al., FREQUENCY OF TRISOMY-20 IN NONMALIGNANT BRONCHIAL EPITHELIUM FROM LUNG-CANCER PATIENTS AND CANCER-FREE FORMER URANIUM MINERS AND SMOKERS, Cancer epidemiology, biomarkers & prevention, 7(11), 1998, pp. 1051-1054
MEDIASTINITIS WITHOUT ANTECEDENT SURGERY
Authors: TEMES RT CROWELL RE MAPEL DW KETAI L PETT SB WERNLY JA
Citation: Rt. Temes et al., MEDIASTINITIS WITHOUT ANTECEDENT SURGERY, The thoracic and cardiovascular surgeon, 46(2), 1998, pp. 84-88
DOUBLE-LABEL SUSPENSION IMMUNOHISTOCHEMISTRY FOR THE DETECTION OF GENE DYSFUNCTION IN SPUTUM
Authors: TIERNEY LA NEFT RE BELINSKY SA LAUER FT GILLILAND FD CROWELL RE LECHNER JF
Citation: La. Tierney et al., DOUBLE-LABEL SUSPENSION IMMUNOHISTOCHEMISTRY FOR THE DETECTION OF GENE DYSFUNCTION IN SPUTUM, Journal of histotechnology, 20(1), 1997, pp. 13-17
GENETIC CHANGES IN LUNG-CANCER - POTENTIAL BIOMARKERS FOR EARLY DETECTION AND PREVENTION
Authors: CROWELL RE BELINSKY SA
Citation: Re. Crowell et Sa. Belinsky, GENETIC CHANGES IN LUNG-CANCER - POTENTIAL BIOMARKERS FOR EARLY DETECTION AND PREVENTION, The Journal of laboratory and clinical medicine, 130(6), 1997, pp. 550-557
SHOCK IN A PATIENT EXPOSED TO RODENTS
Authors: WHITTEN P CROWELL RE LEVY H
Citation: P. Whitten et al., SHOCK IN A PATIENT EXPOSED TO RODENTS, Chest, 112(6), 1997, pp. 1674-1676
CONCURRENT FLUORESCENCE IN-SITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRYFOR THE DETECTION OF CHROMOSOME-ABERRATIONS IN EXFOLIATED BRONCHIAL EPITHELIAL-CELLS
Authors: NEFT RE MURPHY MM TIERNEY LA BELINSKY SA ANDERSON M SACCOMANNO G MICHELS R TIMM S GILLILAND FD CROWELL RE LECHNER JF
Citation: Re. Neft et al., CONCURRENT FLUORESCENCE IN-SITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRYFOR THE DETECTION OF CHROMOSOME-ABERRATIONS IN EXFOLIATED BRONCHIAL EPITHELIAL-CELLS, Acta cytologica, 41(6), 1997, pp. 1769-1773
DETECTION OF TRISOMY-7 IN NONMALIGNANT BRONCHIAL EPITHELIUM FROM LUNG-CANCER PATIENTS AND INDIVIDUALS AT RISK FOR LUNG-CANCER
Authors: CROWELL RE GILLILAND FD TEMES RT HARMS HJ NEFT RE HEAPHY E AUCKLEY DH CROOKS LA JORDAN SW SAMET JM LECHNER JF BELINSKY SA
Citation: Re. Crowell et al., DETECTION OF TRISOMY-7 IN NONMALIGNANT BRONCHIAL EPITHELIUM FROM LUNG-CANCER PATIENTS AND INDIVIDUALS AT RISK FOR LUNG-CANCER, Cancer epidemiology, biomarkers & prevention, 5(8), 1996, pp. 631-637
ADENOCARCINOMA OF THE LUNG PRESENTING AS A DIFFUSE INTERSTITIAL PROCESS IN A 25-YEAR-OLD MAN
Authors: MAPEL DW FEI RH CROWELL RE
Citation: Dw. Mapel et al., ADENOCARCINOMA OF THE LUNG PRESENTING AS A DIFFUSE INTERSTITIAL PROCESS IN A 25-YEAR-OLD MAN, Lung cancer, 15(2), 1996, pp. 239-244
CARDIOPULMONARY MANIFESTATIONS OF HANTAVIRUS PULMONARY SYNDROME
Authors: HALLIN GW SIMPSON SQ CROWELL RE JAMES DS KOSTER FT MERTZ GJ LEVY H
Citation: Gw. Hallin et al., CARDIOPULMONARY MANIFESTATIONS OF HANTAVIRUS PULMONARY SYNDROME, Critical care medicine, 24(2), 1996, pp. 252-258
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
HYPEROXIC SUPPRESSION OF FC-GAMMA RECEPTOR-MEDIATED PHAGOCYTOSIS BY ISOLATED MURINE PULMONARY MACROPHAGES
Authors: CROWELL RE HALLIN G HEAPHY E MOLD C
Citation: Re. Crowell et al., HYPEROXIC SUPPRESSION OF FC-GAMMA RECEPTOR-MEDIATED PHAGOCYTOSIS BY ISOLATED MURINE PULMONARY MACROPHAGES, American journal of respiratory cell and molecular biology, 12(2), 1995, pp. 190-195
INTRAPULMONARY ANTIGEN DEPOSITION IN THE HUMAN LUNG - LOCAL RESPONSES
Authors: WEISSMAN DN BICE DE CROWELL RE SCHUYLER MR
Citation: Dn. Weissman et al., INTRAPULMONARY ANTIGEN DEPOSITION IN THE HUMAN LUNG - LOCAL RESPONSES, American journal of respiratory cell and molecular biology, 11(5), 1994, pp. 607-614
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
Risultati: 1-13 |